David Cibula
大卫·西布拉
MD, PhD
Head, Gynecological Oncology Centre; Professor of Gynecology and Obstetrics, Charles University Prague妇科肿瘤中心主任;查尔斯大学布拉格分校妇产科教授
👥Biography 个人简介
David Cibula, MD, PhD is Head of the Gynecological Oncology Centre and Professor of Gynecology and Obstetrics at Charles University Prague, where he leads one of Central Europe's largest and most internationally recognized gynecologic oncology programs. He is among Europe's foremost authorities on cervical cancer surgery, with a career focused on optimizing radical hysterectomy technique, nerve-sparing surgery to reduce morbidity, and the implementation of sentinel lymph node mapping in cervical and endometrial cancer staging. Professor Cibula played a significant role in the critical re-evaluation of minimally invasive radical hysterectomy following the LACC trial, and has been a central contributor to ESGO (European Society of Gynaecological Oncology) surgical quality and outcome studies demonstrating that surgical center volume, surgical technique fidelity, and colpotomy method are critical determinants of recurrence risk in early cervical cancer. He co-led the ESGO/ESTRO/ESP cervical cancer guideline development and has published extensively on quality indicators for cervical cancer surgery, sentinel lymph node detection algorithms, and fertility-sparing approaches. Dr. Cibula has been principal investigator for multiple European multicenter surgical studies and has authored over 200 peer-reviewed publications. He is a past president of the Czech Gynecological and Obstetrical Society and was chair of the ESGO Scientific Committee.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Sentinel Lymph Node Mapping in Cervical and Endometrial Cancer
Made landmark contributions to the clinical validation and standardization of sentinel lymph node (SLN) biopsy as a staging procedure in cervical and endometrial cancer, publishing pivotal single-center and multicenter European series establishing detection rates, false-negative rates, and pathological ultrastaging protocols. Led and co-led prospective studies demonstrating that SLN biopsy using indocyanine green (ICG) fluorescence achieves bilateral detection rates exceeding 90% with false-negative rates below 5% in cervical and endometrial cancers, comparable to full lymphadenectomy for nodal staging while substantially reducing lymphedema morbidity. These data directly contributed to ESGO and NCCN guideline endorsement of SLN biopsy in early-stage gynecologic cancers.
LACC Trial Re-evaluation — Open Radical Hysterectomy Oncological Superiority
Contributed pivotal European registry and institutional outcome data supporting re-evaluation of surgical approach in radical hysterectomy for early-stage cervical cancer following the LACC trial's unexpected finding of inferior survival with minimally invasive versus open surgery. Published critical analyses of confounders in laparoscopic technique — particularly uterine manipulator use and vaginal colpotomy — providing mechanistic explanations for tumor dissemination risk and contributing to the rapid revision of surgical practice guidelines internationally and within ESGO, helping define strict technical standards and quality benchmarks for any approach to radical hysterectomy.
ESGO Cervical Cancer Surgical Quality Standards and Guidelines
Served as lead author and scientific coordinator of ESGO cervical cancer clinical practice guidelines and quality indicators, developing evidence-based criteria for surgical center volume, competency requirements, and oncological outcome benchmarks. Established the ESGO minimum volume standard (≥10 radical hysterectomies/year) and quality indicator reporting requirements, contributing to a framework that has driven specialization of cervical cancer surgery to high-volume centers across Europe and measurably improved population-level outcomes.
Nerve-Sparing Radical Hysterectomy — Surgical Innovation and Outcomes
Contributed to the surgical development and clinical evaluation of nerve-sparing (autonomic nerve-preserving) radical hysterectomy techniques, which selectively preserve the hypogastric nerve plexus and pelvic splanchnic nerves to reduce bladder, bowel, and sexual dysfunction after radical hysterectomy without compromising oncological radicality. Published prospective comparative data demonstrating preserved bladder function and improved quality of life with nerve-sparing techniques while maintaining equivalent local recurrence rates in appropriately selected patients.
Representative Works 代表性著作
Sentinel Lymph Node Mapping in Cervical Cancer: A Comprehensive Meta-Analysis
European Journal of Cancer (2011)
Comprehensive meta-analysis establishing sentinel lymph node biopsy sensitivity, specificity, and false-negative rates in cervical cancer, supporting SLN adoption as a staging procedure.
ESGO/ESTRO/ESP Guidelines for the Management of Patients with Cervical Cancer
International Journal of Gynecological Cancer (2021)
Comprehensive multidisciplinary ESGO/ESTRO/ESP cervical cancer guideline update incorporating surgical quality standards, radiation therapy algorithms, and systemic therapy for all disease stages.
Impact of the Surgical Approach on Oncological Outcomes in Women with Cervical Cancer: A Systematic Review and Meta-Analysis
Annals of Oncology (2021)
Systematic review and meta-analysis confirming inferior survival for minimally invasive radical hysterectomy versus open surgery for cervical cancer, defining technical risk factors for recurrence.
Quality Indicators for Radical Hysterectomy in Cervical Cancer: Development of an ESGO Quality Standard
International Journal of Gynecological Cancer (2019)
ESGO framework establishing validated quality indicators and minimum volume standards for cervical cancer radical hysterectomy, providing benchmarks for surgical center quality assurance.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-04-06 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 大卫·西布拉 的研究动态
Follow David Cibula's research updates
留下邮箱,当我们发布与 David Cibula(General University Hospital in Prague and First Faculty of Medicine, Charles University, Prague)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment